Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06587191
Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
View on ClinicalTrials.gov
Summary
The goal of this retrospective study is to assess efficacy and safety of emapalumab prescribed for the treatment in children with refractory from of pHLH.
Official title: Retrospective Non-interventional Study Assessing Efficacy and Safety of Emapalumab in Children With Primary Hemophagocytic Lymphohistiocytosis (pHLH)
Key Details
Gender
All
Age Range
1 Day - 18 Years
Study Type
OBSERVATIONAL
Enrollment
7
Start Date
2024-08-01
Completion Date
2024-10-01
Last Updated
2024-10-01
Healthy Volunteers
No
Locations (1)
Research Institute of Pediatric Hematology, Oncology and Immunology
Moscow, Russia